LifeBond

About:

LifeBond is a leader in the development and manufacturing of biosurgical medical devices for tissue repair

Website: http://www.life-bond.com

Twitter/X: lifebondmed

Top Investors: Trendlines Group, Pitango VC, Giza Venture Capital, GlenRock Israel, Sino Biopharmaceutical

Description:

LifeBond is a leader in the development and manufacturing of bio-surgical medical devices for tissue repair that are intended to improve the recovery of patients and to create an environment that supports the body’s natural healing process and promotes tissue repair. Of natural origin, elastic, adhesive, durable and yet absorbable, the company’s devices can be used to fill a long list of unmet surgical needs. LifeBond’s first product, LifeSeal™, is designed to provide staple-line reinforcement in bariatric and colorectal operations. It was recently studied in an international pilot clinical study in Europe. The company’s second pipeline product, LifeMesh™, a self-fixating hernia mesh, is in pre-clinical development. Other pipeline products include tissue adhesives and absorbable hemostats. LifeSeal™, LifeMesh™ and other LifeBond™ products are investigational and have not yet been approved for sale in the US or in any other market. For more information please visit use at: www.life-bond.com

Total Funding Amount:

$56.5M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Caesarea, Hefa, Israel

Founded Date:

2007-01-01

Contact Email:

info(AT)life-bond.com

Founders:

Ishay Attar, Orahn Preiss Bloom

Number of Employees:

1-10

Last Funding Date:

2015-08-05

IPO Status:

Private

Industries:

© 2025 bioDAO.ai